PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION

被引：0
|
作者：
KLINTMALM, GBG
GOLDSTEIN, R
GONWA, T
WIESNER, RH
KROM, RAF
SHAW, BW
STRATTA, R
ASCHER, NL
ROBERTS, JW
LAKE, J
BUSUTTIL, RW
MCDIARMID, S
ESQUIVEL, CO
NAKAZATO, P
MARSH, JW
WOODLE, ES
KALAYOGLU, M
DALESSANDRO, AM
PIRSCH, JD
MILLER, C
SCHWARTZ, M
LEWIS, WD
MONACO, AP
JENKINS, RL
EMOND, JC
THISTLETHWAITE, JR
WHITINGTON, PF
STEINMULLER, DR
FITZSIMMONS, WE
LAWRENCE, I
机构：
[1] FUJISAWA PHARMACEUT CO,4 N,3 PKWY N CTR,DEERFIELD,IL 60015
[2] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
[3] BAYLOR UNIV,MED CTR,DALLAS,TX
[4] ROCHESTER METHODIST HOSP,ROCHESTER,MN
[5] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO MED CTR,SAN FRANCISCO,CA 94143
[6] UNIV CALIF LOS ANGELES,LOS ANGELES MED CTR,LOS ANGELES,CA 90024
[7] CALIFORNIA PACIFIC MED CTR,SAN FRANCISCO,CA
[8] UNIV WISCONSIN HOSP & CLIN,MADISON,WI
[9] DEACONESS HOSP,BOSTON,MA
[10] UNIV CHICAGO,MED CTR,CHICAGO,IL 60637
[11] UNIV NEBRASKA,MED CTR,OMAHA,NE 68105
[12] BARNES HOSP,ST LOUIS,MO 63110
[13] MT SINAI MED CTR,NEW YORK,NY 10029
来源：
TRANSPLANTATION PROCEEDINGS | 1993年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：641 / 643
页数：3
相关论文
共 50 条
  • [31] TOXICITY VERSUS REJECTION - OR WHY SWITCHES BETWEEN CYCLOSPORINE-A AND FK-506 WERE PERFORMED FOLLOWING LIVER-TRANSPLANTATION
    PLATZ, KP
    MUELLER, AR
    BLUMHARDT, G
    NEUHAUS, P
    HEPATOLOGY, 1993, 18 (03) : 745 - 745
  • [32] FK-506 RESCUE THERAPY FOR REFRACTORY ACUTE REJECTION IN 5 LIVER RECIPIENTS
    RUCAY, P
    SAMUEL, D
    GILLET, D
    BISMUTH, H
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3000 - 3001
  • [33] FK-506 USED AS RESCUE THERAPY FOR REFRACTORY LIVER ALLOGRAFT-REJECTION
    CHEN, CL
    ENG, HL
    CHEN, YS
    KUO, YC
    SUN, CK
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (04) : 1927 - 1929
  • [34] CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506
    MCCAULEY, J
    FUNG, JJ
    TODO, S
    JAIN, A
    DEBALLI, P
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3143 - 3145
  • [35] A COMPARISON OF THE RENAL EFFECTS (ERPF, GFR, AND FF) OF FK-506 AND CYCLOSPORINE IN PATIENTS WITH LIVER-TRANSPLANTATION
    TAUXE, WN
    MOCHIZUKI, T
    MCCAULEY, J
    STARZL, TE
    JAIN, A
    CHARRON, M
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3146 - 3147
  • [36] COMPARING NEPHROTOXICITY OF FK-506 AND CYCLOSPORINE REGIMENS AFTER LIVER-TRANSPLANTATION - PRELIMINARY-RESULTS FROM US MULTICENTER TRIAL
    PORAYKO, MK
    GONWA, TA
    KLINTMALM, GB
    WIESNER, RH
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1114 - 1116
  • [37] CONVERSION FROM CYCLOSPORINE TO FK-506 IN LIVER ALLOGRAFT RECIPIENTS WITH CYCLOSPORINE-RELATED COMPLICATIONS
    FUNG, JJ
    TODO, S
    JAIN, A
    MCCAULEY, J
    ALESSIANI, M
    SCOTTI, C
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (01) : 6 - 12
  • [38] FK 506 therapy for refractory renal allograft rejection: Lessons from liver transplantation
    Woodle, ES
    Bruce, DS
    Josephson, M
    Newell, KA
    Piper, JB
    Millis, JM
    Cronin, D
    Whitman, G
    Ruebe, M
    Thistlethwaite, JR
    CLINICAL TRANSPLANTATION, 1996, 10 (04) : 323 - 332
  • [39] FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION
    WOODLE, ES
    PERDRIZET, GA
    BRUNT, EM
    SO, SKS
    JENDRISAK, MD
    MCCULLOUGH, CS
    VEHE, KL
    WHITE, HM
    PETERS, MG
    MARSH, JW
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 2992 - 2993
  • [40] REDUCED INCIDENCE OF ACUTE, REFRACTORY ACUTE, AND CHRONIC REJECTION AFTER LIVER-TRANSPLANTATION WITH FK506-BASED IMMUNOSUPPRESSION
    MCMASTER, P
    BISMUTH, H
    CALNE, R
    GROTH, C
    NEUHAUS, P
    OTTO, G
    PICHLMAYR, R
    WILLIAMS, R
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3260 - 3263
12345